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supraclavicular and axillary nodes 7 months after PBI in a 
patient with negative sentinel node. Nine patients developed 
distant metastases, 16 patients a contralateral breast cancer 
and 35 patients a second primary cancer. At the last check-
up 240 patients were alive: 238 with no evidence of cancer, 2 
with metastatic breast cancer. 15 patients died: 4 of 
metastatic breast cancer, 5 of another cancer, 3 of different 
causes. The 5-year probability of breast relapse-free survival, 
nodal relapse-free survival and cause specific-free survival 
were 98.1% (95% CI: 96.3-100 ) 99% (95% CI: 97.7-100 ) and 
99.5%(95% CI: 98.4-100 ) respectively. Acute toxicity occurred 
in 95 patients and late toxicity in 85 patients. From different 
risk factors for toxicity (age, tumor size, hormonal therapy, 
chemotherapy) only tamoxifen, was significant factor for late 
toxicity (p<0.0001). Cosmetic results were excellent/good in 
250 patients, fair in 6, unknown in 4. Overall inter-rater 
agreement by physicians and patients on cosmesis was good 
(K value: 0.67). 
Conclusions: Our data demonstrate that PBI with 192Ir 
interstitial multi-catheter HDR brachytherapy is associated 
with a relapse rate comparable to the best published results 
and low late toxicity.  
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Purpose/Objective: Incidence of breast cancer (BC) is 
increasing in the elderly population because of the increase 
in life expectancy and the diffusion of screening trials. Even 
in patients with BC of excellent prognosis, ipsilateral breast 
tumour recurrence (IBTR) after conservative surgery without 
adjuvant therapy is still very high. IBTR was reduced by 
either radiotherapy (RT) or hormonal therapy but to a greater 
extent by the receipt of both treatments. Whole breast 
irradiation (WBI) remains the standard of care after 
conserving surgery but the management of adjuvant radiation 
therapy in the elderly has become a medical challenge 
because of the poor compliance of patients to conventional 
RT. We analyzed the recurrences rate and the safety profile 
of a subset of patients age 70 years or older of a phase 3 trial 
comparing APBI and WBI. 
Materials and Methods: The trial enrolled 520 women aged 
more than 40 years affected by early BC, with a maximum 
pathological tumour size of 25 mm. Patients were randomly 
assigned in a 1:1 ratio to receive either WBI or APBI using 
IMRT. The APBI arm received a total dose of 30 Gy to the 
tumour bed in 5 daily fractions. The WBI arm received 50 Gy 
in 25 fractions, followed by a boost of 10 Gy in 5 fractions. 
The primary endpoint was occurrence of IBTR; this trial is 
registered with ClinicalTrials.gov, number NCT02104895. 
Results: A total of 114 patients aged more than 70 years 
were analysed (58 in the WBI arm, 56 in the APBI arm). Most 
patients had pathological T1 stage (86%), nuclear grade G1-2 
(73.2%), positive hormonal status (94.7%), negative HER2 
status (83.3%), and luminal-A molecular subtype (74.6%); all 
these features were well balanced between the two arms. 
At a median follow-up of 5.0 years (range 3.4-7.0), the IBTR 
rate was 2% (one case) in the APBI group and 1.9% in the WBI 
group (one case). No significant difference emerged between 
the two groups (log rank test p=0.93). The APBI group 
presented significantly better results considering acute skin 
toxicity (p=0.0001). Major recorded events and safety profile 
of this subgroup of patients were presented in Table 1. 
 
 
Conclusions: Our results confirmed the low rate of IBTR in 
this subgroup of patients, which could benefit in terms of 
quality of life in a reduction of irradiated volume. Omission 
of WBI after conservative surgery in elderly is still 
controversial, according to the indolent behaviour of BC in 
these patients. Further investigations are strongly needed to 
select a subset of tumours of excellent prognosis, such as 
luminal A, to treat with exclusive APBI or hormonal therapy. 
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Purpose/Objective: To report 2-year cosmetic outcome of a 
randomized trial comparing prone and supine whole-breast 
irradiation (WBI) in large breasted patients 
Materials and Methods: Between December 29, 2010, and 
December 12, 2012, 100 patients with at least a (European) 
cup size C presenting for WBI were randomized between 
supine multi-beam and prone tangential field intensity 
modulated radiotherapy. All patients were treated to 40,05 
Gy in 15 fractions, followed by a boost of 10 Gy in 4 fractions 
if indicated. Digital photographs were taken in standard 
conditions before and 2-year after radiotherapy with markers 
on the nipples, the suprasternal notch and the xyphoid. A 
photograph was taken with the arms alongside the body one 
with the arms up. Cosmesis was objectively scored using the 
commercially available BCCT.core software of the INESC 
Porto Breast Research Group (1). A subjective scoring was 
done by 3 observers on a 4-point scale: excellent – good – fair 
– poor. The difference in cosmesis was analyzed with 0 – no 
difference or better cosmesis, 1 – cosmesis one category 
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worse, and 2 – cosmesis two categories worse after 
radiotherapy. For the subjective score the median difference 
for the 3 observers was considered. At submission of this 
abstract 2-year cosmetic outcome was available for 82/100 
patients (39 prone and 43 supine treated). All patients will 
have reached 2-year follow up in January 2014 and final 
results will be available for presentation at the 3rd ESTRO 
Forum. 
Results: Patient and treatment characteristics were not 
significantly different between both cohorts. Figure 1 shows 
the interim data. Neither objective, nor subjective cosmetic 
outcome was significantly different between prone and 
supine treated patients. On the photographs with the hands 
up, more patients in the supine group had a worsening of 
cosmesis of 2 categories using the BCCT.org software (6/43 
versus 0/39 in the prone cohort, p = 0.053). 
 
Conclusions: Interim analysis shows no significant differences 
in cosmetic outcome between prone and supine WBI after a 
limited follow-up of 2-year. Final data will be presented at 
the 3rd ESTRO Forum.  
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Purpose/Objective: To investigate heart position 
reproducibility on cone-beam CT (CBCT) during voluntary 
moderate deep inspiration breath-hold (mDIBH) for 
radiotherapy of left-sided breast cancer patients. 
Materials and Methods: For 20 consecutive left-sided breast 
cancer patients, FB and mDIBH CT datasets were acquired. 
Both scans were registered on the breast and chest wall. 
Heart position with respect to chest wall (HP-CW) was 
measured on both scans in the transversal slice where the 
heart was nearest to the chest wall at the level of the 
tangential fields, i.e. nearest to the field edge of the 
treatment beams, perpendicular to the tangential field edge. 
The change in HP-CW on the FB scan relative to the mDIBH 
scan was quantified as ΔHP-CW. Treatment planning was based 
on the mDIBH CT scan. For 50 additional consecutive 
patients, who are treated with tangential IMRT beams, CBCT 
scans were made during mDIBH for position verification and 
setup correction. During treatment breath-hold was 
monitored using an in-house developed tool, resulting in an 
accurate and reproducible position of the breast and chest 
wall during mDIBH. On the CBCT scans the difference in heart 
position with respect to the reference mDIBH CT was 
measured after registration, in order to quantify the change 
in heart position relative to the chest wall (ΔHP-CW). 
Results: On the FB scan heart position was on average 10.8 ± 
5.1 mm (range 3.5 – 21.7 mm) closer to the chest wall 
compared to the mDIBH scan (indicated as a negative ΔHP-CW 
in Figure 1). Despite the breath-hold, the heart was on 
average 4.7 ± 8.3 mm (range -21 – +12 mm) inside the 
radiation field on the initial planning mDIBH CT scan.  
At fraction 1, the average ΔHP-CW was -0.8 ± 5.2 mm, i.e. the 
breath-hold was less deep than during planning CT. During 
the total treatment, the average ΔHP-CW was 0.9 ± 4.4 mm 
(range -8.3 – +10.4 mm, Figure 1), suggesting a trend towards 
progressively deeper inspiration during the rest of the 
treatment course. However, there was a large interfraction 
variation per patient in ΔHP-CW over the treatment course with 
an average standard deviation of 3.1 mm. 
 
 
Figure 1: Distribution of ΔHP-CW between FB and mDIBH CT-
scan (red, n=20), and average ΔHP-CW between CBCT and 
mDIBH CT (blue, n=50). 
 
Conclusions: In this study, applying voluntary mDIBH always 
decreased the amount of heart inside the treatment volume. 
Despite the large interfraction variation, on average the 
distance between heart and chest wall increased during 
treatment. Therefore, voluntary mDIBH is sufficient for the 
majority of the patients, although some patients might 
benefit from an online feature that monitors both chest wall 
and heart position during breath-hold.  
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